Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Capital/Financing Update 2020

Apr 19, 2020

65044_rns_2020-04-19_aba4513f-5cbe-4452-b23d-799c35921b5e.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [215 x 49] intentionally omitted <==

Holista CollTech Limited

(ASX:HCT / ABN 24 094 515 992) 283 Rokeby Road Subiaco WA 6008 P: +61 8 6141 3500; F: +61 8 6141 3599 W: www.holistaco.com

ASX Announcement

20 April 2020

CONTROLLED PLACEMENT AGREEMENT

KUALA LUMPUR/PERTH, 20 April 2020 – Holista CollTech (ASX:HCT, “Holista”), is pleased to announce that it has utilised its Controlled Placement Agreement with Acuity Capital (“ CPA ”) to issue 12,000,000 HCT ordinary fully paid shares at an issue price of $0.1833 to raise $2,200,000 (inclusive of costs).

The issue price of $0.1833 represents a premium of 12.8% to the 15 day VWAP up to 20 April 2020 (inclusive) and a 6% discount to the closing price of $0.195 on 20 April 2020.

The Company advises that total capital now provided utilising the CPA, including the $2.2m the subject of this announcement, is $6.5M.

The shares will be issued out of the Company’s LR 7.1 and 7.1A capacity with an Appendix 2A and cleansing notice following on confirmation of share allotment on 21 April 2020.

Authorised by:

Stuart Usher

Company Secretary

#END OF PRESS RELEASE#

About Holista CollTech Ltd

Holista CollTech Ltd (“Holista”) is a natural wellness company, the result of a merger between Holista Biotech Sdn Bhd and CollTech Australia Ltd. The company has 3 main divisions:

  • Dietary supplements and personal care

  • Food Ingredients

  • Ovine collagen

Holista has a global collaboration for Path-Away®, a plant-based solution that is proven to kill a broad spectrum of microbes. The all-natural alcohol-free solution is an active ingredient in Holista’s proprietary hand sanitiser, NatShield™ that is sold under its personal care range.

Holista researches, develops, manufactures and markets “health-style” products to address the unmet and evolving needs of natural medicine. Holista’s suite of ingredients includes low-GI baked products, reduced-sodium salts, low-fat fried foods and low-calorie sugar without compromising taste, odour and mouthfeel. Holista remains the only company to produce sheep (ovine) collagen using patented extraction methods.

For more information, please refer to http://www.holistaco.com

For further information, please contact:

Corporate Affairs & Business Opportunities

Dr Rajen Manicka: [email protected]

Media and Investor Relations Enquiries

Australia and New Zealand

Julia Maguire | Co-Founder & Executive Director The Capital Network Level 14, 234 George Street Sydney NSW 2000 Australia +61 419 815 386

julia @thecapitalnetwork.com.au

Global

Lai Kwok Kin, Founder and Managing Director WeR1 Consultants Pte Ltd 3 Phillip Street #12-01 Singapore 048693 E: [email protected] P: +65 67374844